pamol 24 mg/ml oraalisuspensio
orifarm healthcare a/s - paracetamol - oraalisuspensio - 24 mg/ml - parasetamoli
nicorette fruit 2 mg imeskelytabletti
mcneil / jntl consumer health (finland) oy - nicotine resinate - imeskelytabletti - 2 mg - nikotiini
nicorette fruit 4 mg imeskelytabletti
mcneil / jntl consumer health (finland) oy - nicotine resinate - imeskelytabletti - 4 mg - nikotiini
felpreva
vétoquinol sa - emodepside, praziquantel, tigolaner - matolääkkeet, - kissat - for cats with, or at risk from, mixed parasitic infestations. the veterinary medicinal product is exclusively indicated when ectoparasites, cestodes and nematodes are targeted at the same time.
teglutik 5 mg/ml oraalisuspensio
italfarmaco sa - riluzole - oraalisuspensio - 5 mg/ml - rilutsoli
adrovance
n.v. organon - colecalciferol, alendronic acid (as sodium trihydrate) - osteoporoosi, postmenopausaalinen - lääkkeet luusairauksien hoitoon - postmenopausaalisen osteoporoosin hoito potilailla, joilla on d-vitamiinin vajaatoiminta. adrovance vähentää nikama-ja lonkkamurtumia.
aerinaze
n.v. organon - desloratadine, pseudophedrine sulfate - nuha, allerginen, kausiluonteinen - nenäselkävalmisteet - kausiluonteisen allergisen nuhan oireellinen hoito, kun se liittyy nenän tukkoisuuteen.
aerius
n.v. organon - desloratadiinia - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - systeemiset antihistamiinit, - aerius on tarkoitettu tarkoitettu oireiden lievittämiseen kanssa:allerginen nuha, nokkosihottuma,.
azomyr
n.v. organon - desloratadiinia - rhinitis, allergic, perennial; urticaria; rhinitis, allergic, seasonal - systeemiset antihistamiinit, - azomyr is indicated for the relief of symptoms associated with:allergic rhinitis (see section 5. 1)urticaria (see section 5.
elonva
n.v. organon - corifollitropiini alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - sukupuolihormonit ja genitaalijärjestelmään vaikuttavat aineet, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).